Business Description
Greenyn Biotechnology Co Ltd
ISIN : TW0006846009
Description
Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.91 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | 0.31 | |||||
| Interest Coverage | 93.09 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 8.26 | |||||
| Beneish M-Score | -2.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.4 | |||||
| 3-Year EBITDA Growth Rate | -2.1 | |||||
| 3-Year EPS without NRI Growth Rate | -1.1 | |||||
| 3-Year FCF Growth Rate | -48.3 | |||||
| 3-Year Book Growth Rate | 11.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.26 | |||||
| 9-Day RSI | 47.08 | |||||
| 14-Day RSI | 48.13 | |||||
| 6-1 Month Momentum % | -0.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.69 | |||||
| Quick Ratio | 3.79 | |||||
| Cash Ratio | 2.95 | |||||
| Days Inventory | 127.1 | |||||
| Days Sales Outstanding | 42.96 | |||||
| Days Payable | 42.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.52 | |||||
| Dividend Payout Ratio | 0.71 | |||||
| Forward Dividend Yield % | 4.52 | |||||
| 5-Year Yield-on-Cost % | 4.52 | |||||
| 3-Year Average Share Buyback Ratio | -3.9 | |||||
| Shareholder Yield % | 2.62 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.25 | |||||
| Operating Margin % | 19.11 | |||||
| Net Margin % | 15.66 | |||||
| FCF Margin % | 9.63 | |||||
| ROE % | 17.14 | |||||
| ROA % | 12.26 | |||||
| ROIC % | 28.95 | |||||
| ROC (Joel Greenblatt) % | 58.81 | |||||
| ROCE % | 20.47 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.68 | |||||
| Forward PE Ratio | 13.04 | |||||
| PE Ratio without NRI | 15.68 | |||||
| PS Ratio | 2.45 | |||||
| PB Ratio | 2.58 | |||||
| Price-to-Tangible-Book | 2.59 | |||||
| Price-to-Free-Cash-Flow | 25.37 | |||||
| Price-to-Operating-Cash-Flow | 12.26 | |||||
| EV-to-EBIT | 9.69 | |||||
| EV-to-EBITDA | 8.28 | |||||
| EV-to-Revenue | 1.93 | |||||
| EV-to-FCF | 20.3 | |||||
| Price-to-Graham-Number | 1.34 | |||||
| Price-to-Net-Current-Asset-Value | 3.77 | |||||
| Price-to-Net-Cash | 7.8 | |||||
| Earnings Yield (Greenblatt) % | 10.32 | |||||
| FCF Yield % | 3.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Greenyn Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 847.615 | ||
| EPS (TTM) (NT$) | 4.9 | ||
| Beta | 0 | ||
| Volatility % | 16.96 | ||
| 14-Day RSI | 48.13 | ||
| 14-Day ATR (NT$) | 1.223238 | ||
| 20-Day SMA (NT$) | 76.995 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (NT$) | 71 - 84 | ||
| Shares Outstanding (Mil) | 26.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Greenyn Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Greenyn Biotechnology Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Greenyn Biotechnology Co Ltd Frequently Asked Questions
What is Greenyn Biotechnology Co Ltd(ROCO:6846)'s stock price today?
The current price of ROCO:6846 is NT$76.80. The 52 week high of ROCO:6846 is NT$84.00 and 52 week low is NT$71.00.
When is next earnings date of Greenyn Biotechnology Co Ltd(ROCO:6846)?
The next earnings date of Greenyn Biotechnology Co Ltd(ROCO:6846) is .
Does Greenyn Biotechnology Co Ltd(ROCO:6846) pay dividends? If so, how much?
The Dividend Yield %  of Greenyn Biotechnology Co Ltd(ROCO:6846) is 4.52% (As of Today), Highest Dividend Payout Ratio of Greenyn Biotechnology Co Ltd(ROCO:6846) was 0.78. The lowest was 0.6. And the median was 0.69. The  Forward Dividend Yield % of Greenyn Biotechnology Co Ltd(ROCO:6846) is 4.52%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers